Work

NextGen cell-based immunotherapies in cancer and other immune disorders

Year: 2019

Type: review

Source: Current Opinion in Immunology

DOI: 10.1016/j.coi.2019.03.007

Authors: Camillia S. Azimi, Qizhi Tang, Kole T Roybal, Jeffrey A Bluestone

Institutions: University of California, San Francisco, Chan Zuckerberg Biohub San Francisco, Parker Institute for Cancer Immunotherapy, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, Parker Institute for Cancer Immunotherapy, Juvenile Diabetes Research Foundation New Zealand, Emerson Collective, Cancer Research UK, Norges Idrettshøgskole, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco

Awards: Molecular and Cellular Immunology, Engineering the Next-generation of Custom Immune Cell Therapies, G4826108991

OpenAlex ID: W2943844881

FWCI: 0.262

Cites: 76

Cited by: 15

Related to: 10